Aimee Donnellan, a columnist and author focusing on Ozempic, delves into how GLP-1 weight-loss drugs work, their potential risks, and the significant impact on obesity treatment. She reveals the drug's biological effects on hunger and cravings and discusses the implications of discontinuation. Meanwhile, David McWilliams, a former central bank economist, explores the fascinating history of money as a social technology, its role in civilization, and the psychological influences it has on our lives. Both guests provide deep insights into contemporary issues affecting health and wealth.
